Literature DB >> 16957039

Genotyping hepatitis C viruses from Southeast Asia by a novel line probe assay that simultaneously detects core and 5' untranslated regions.

Suwanna Noppornpanth1, Erwin Sablon, Kathy De Nys, Xuan Lien Truong, Jan Brouwer, Marianne Van Brussel, Saskia L Smits, Yong Poovorawan, Albert D M E Osterhaus, Bart L Haagmans.   

Abstract

Hepatitis C viruses (HCVs) display a high level of sequence diversity and are currently divided into six genotypes. A line probe assay (LiPA), which targets the 5' untranslated region (5'UTR) of the HCV genome, is widely used for genotyping. However, this assay cannot distinguish many genotype 6 subtypes from genotype 1 due to high sequence similarity in the 5'UTR. We investigated the accuracy of a new generation LiPA (VERSANT HCV genotype 2.0 assay), in which genotyping is based on 5'UTR and core sequences, by testing 75 selected HCV RNA-positive sera from Southeast Asia (Vietnam and Thailand). For comparison, sera were tested on the 5'UTR based VERSANT HCV genotype assay and processed for sequence analysis of the 5'UTR-to-core and NS5b regions as well. Phylogenetic analysis of both regions revealed the presence of genotype 1, 2, 3, and 6 viruses. Using the new LiPA assay, genotypes 6c to 6l and 1a/b samples were more accurately genotyped than with the previous test only targeting the 5'UTR (96% versus 71%, respectively). These results indicate that the VERSANT HCV genotype 2.0 assay is able to discriminate genotypes 6c to 6l from genotype 1 and allows a more accurate identification of genotype 1a from 1b by using the genotype-specific core information.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16957039      PMCID: PMC1698374          DOI: 10.1128/JCM.01122-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

Review 1.  Review: molecular epidemiology of hepatitis C virus.

Authors:  D B Smith; P Simmonds
Journal:  J Gastroenterol Hepatol       Date:  1997-07       Impact factor: 4.029

2.  Variation of the hepatitis C virus 5' non-coding region: implications for secondary structure, virus detection and typing. The International HCV Collaborative Study Group.

Authors:  D B Smith; J Mellor; L M Jarvis; F Davidson; J Kolberg; M Urdea; P L Yap; P Simmonds
Journal:  J Gen Virol       Date:  1995-07       Impact factor: 3.891

3.  Evaluation and comparison of different hepatitis C virus genotyping and serotyping assays.

Authors:  J H Lee; W K Roth; S Zeuzem
Journal:  J Hepatol       Date:  1997-05       Impact factor: 25.083

4.  Typing of hepatitis C virus by a new method based on restriction fragment length polymorphism.

Authors:  S Buoro; S Pizzighella; R Boschetto; L Pellizzari; M Cusan; R Bonaguro; C Mengoli; C Caudai; M Padula; P Egisto Valensin; G Palù
Journal:  Intervirology       Date:  1999       Impact factor: 1.763

Review 5.  Molecular methods of hepatitis C genotyping.

Authors:  Karen Weck
Journal:  Expert Rev Mol Diagn       Date:  2005-07       Impact factor: 5.225

6.  Survey of type 6 group variants of hepatitis C virus in Southeast Asia by using a core-based genotyping assay.

Authors:  J Mellor; E A Walsh; L E Prescott; L M Jarvis; F Davidson; P L Yap; P Simmonds
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

7.  Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cells.

Authors:  Anne-Marie Roque-Afonso; Delphine Ducoulombier; Gaëtana Di Liberto; Rachid Kara; Michele Gigou; Elisabeth Dussaix; Didier Samuel; Cyrille Féray
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

8.  Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group.

Authors:  N N Zein; J Rakela; E L Krawitt; K R Reddy; T Tominaga; D H Persing
Journal:  Ann Intern Med       Date:  1996-10-15       Impact factor: 25.391

9.  Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.

Authors:  J G McHutchison; S C Gordon; E R Schiff; M L Shiffman; W M Lee; V K Rustgi; Z D Goodman; M H Ling; S Cort; J K Albrecht
Journal:  N Engl J Med       Date:  1998-11-19       Impact factor: 91.245

10.  Evolutionary analysis of variants of hepatitis C virus found in South-East Asia: comparison with classifications based upon sequence similarity.

Authors:  P Simmonds; J Mellor; T Sakuldamrongpanich; C Nuchaprayoon; S Tanprasert; E C Holmes; D B Smith
Journal:  J Gen Virol       Date:  1996-12       Impact factor: 3.891

View more
  17 in total

1.  Superior response to pegylated interferon and ribavirin in Asians with chronic hepatitis C.

Authors:  Venessa Pattullo; E Jenny Heathcote; David K H Wong
Journal:  Hepatol Int       Date:  2010-08-08       Impact factor: 6.047

Review 2.  Hepatitis C virus genotype 6: virology, epidemiology, genetic variation and clinical implication.

Authors:  Vo Duy Thong; Srunthron Akkarathamrongsin; Kittiyod Poovorawan; Pisit Tangkijvanich; Yong Poovorawan
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

3.  Performance evaluation of the new Roche cobas AmpliPrep/cobas TaqMan HCV test, version 2.0, for detection and quantification of hepatitis C virus RNA.

Authors:  S Pas; R Molenkamp; J Schinkel; S Rebers; C Copra; S Seven-Deniz; D Thamke; R J de Knegt; B L Haagmans; M Schutten
Journal:  J Clin Microbiol       Date:  2012-11-14       Impact factor: 5.948

Review 4.  Hepatitis C genotype 6: A concise review and response-guided therapy proposal.

Authors:  Chalermrat Bunchorntavakul; Disaya Chavalitdhamrong; Tawesak Tanwandee
Journal:  World J Hepatol       Date:  2013-09-27

5.  Correlation of the 5'untranslated region (5'UTR) and non-structural 5B (NS5B) nucleotide sequences in hepatitis C virus subtyping.

Authors:  Michael O Baclig; Veronica F Chan; John Donnie A Ramos; Juliet Gopez-Cervantes; Filipinas F Natividad
Journal:  Int J Mol Epidemiol Genet       Date:  2010-07-07

6.  Evaluation of a new assay in comparison with reverse hybridization and sequencing methods for hepatitis C virus genotyping targeting both 5' noncoding and nonstructural 5b genomic regions.

Authors:  Elisa Martró; Victoria González; Andrew J Buckton; Verónica Saludes; Gema Fernández; Lurdes Matas; Ramón Planas; Vicenç Ausina
Journal:  J Clin Microbiol       Date:  2007-11-07       Impact factor: 5.948

7.  Nine additional complete genome sequences of HCV genotype 6 from Vietnam including new subtypes 6xb and 6xc.

Authors:  Chunhua Li; Van H Pham; Kenji Abe; Ling Lu
Journal:  Virology       Date:  2014-08-30       Impact factor: 3.616

8.  Evaluation of Versant hepatitis C virus genotype assay (LiPA) 2.0.

Authors:  Jannick Verbeeck; Mark J Stanley; Jen Shieh; Linda Celis; Els Huyck; Elke Wollants; Judy Morimoto; Alice Farrior; Erwin Sablon; Margaret Jankowski-Hennig; Carl Schaper; Pamela Johnson; Marc Van Ranst; Marianne Van Brussel
Journal:  J Clin Microbiol       Date:  2008-04-09       Impact factor: 5.948

9.  Performance comparison of the versant HCV genotype 2.0 assay (LiPA) and the abbott realtime HCV genotype II assay for detecting hepatitis C virus genotype 6.

Authors:  Ruifeng Yang; Xu Cong; Shaocai Du; Ran Fei; Huiying Rao; Lai Wei
Journal:  J Clin Microbiol       Date:  2014-08-06       Impact factor: 5.948

10.  Hepatitis C virus genotyping methods: evaluation of AmpliSens(®) HCV-1/2/3-FRT compared to sequencing method.

Authors:  Nurul Azmawati Mohamed; Zetti Zainol Rashid; Kon Ken Wong
Journal:  J Clin Lab Anal       Date:  2014-01-29       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.